Patents Assigned to Chengdu MFS Pharma. Co., Ltd.
  • Patent number: 11434205
    Abstract: A compound is shown in formula (I). The derivatives of the compound include a stereoisomer, a pharmaceutically acceptable salt, a solvate, a prodrug, a metabolite, a deuterated derivative. The compound is a structurally novel substituted imidazole formate derivative. Substituted imidazole formate derivatives are used in preparing a drug with sedative, hypnotic and/or anesthetic effects, as well as a drug that can control the state of epilepsy. The compound has a good inhibitory effect on the central nervous system, and provides a new option for clinical screening of and/or preparation of a drug with sedative, hypnotic and/or anesthetic effects and controlling the state of epilepsy.
    Type: Grant
    Filed: January 30, 2019
    Date of Patent: September 6, 2022
    Assignee: Chengdu MFS Pharma. Co., Ltd.
    Inventors: Haijun Ma, Changhua Wang, Zhenbiao Xie